Clincosm LogoSign in Get a demo

ASPECT: Child Asthma : What Parents Attitude During an Asthma Attack at Home Before Consulting the Pediatric Emergencies

Sponsor
University Hospital, Brest (Other)
Overall Status
Completed
CT.gov ID
NCT03967873
Collaborator
(none)
350
Enrollment
2
Locations
20.7
Actual Duration (Months)
175
Patients Per Site
8.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

prospective multicenter observational study. Parents whose children meet the inclusion criteria complete a questionnaire assessing the child's follow-up, the management of the current asthma attack, and the treatment provided at home.

The main objective is to calculate the prevalence of placement of short-acting bronchodilators. The secondary objectives are to describe the factors associated with their implementation.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    350 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Prevalence of Preoperative Short-acting Mimetic beta2 Therapy by Parents of Asthmatic Children Attending Emergency Room for Asthma Attack
    Actual Study Start Date :
    Oct 9, 2018
    Actual Primary Completion Date :
    Jun 30, 2020
    Actual Study Completion Date :
    Jun 30, 2020

    Outcome Measures

    Primary Outcome Measures

    1. prevalence of short-acting bronchodilator induction in children attending emergency room for asthma attack [1 hour]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Years to 15 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • child over 2 years emergency room consultant for asthma attack

    • child whose parents did not express their opposition to participate and completed the non-objection form

    • child consultant in pediatric emergencies of Quimper and Brest

    Exclusion Criteria:

    • child whose age is not between 2 and 15 years old

    • cough equivalent of asthma

    • history of cardiac or pulmonary pathology or prematurity

    • refusal to participate

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHRU de Brest Brest France 29609
    2 Ch Quimper Quimper France 29000

    Sponsors and Collaborators

    • University Hospital, Brest

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Brest
    ClinicalTrials.gov Identifier:
    NCT03967873
    Other Study ID Numbers:
    • ASPECT (29BRC18.0201)
    First Posted:
    May 30, 2019
    Last Update Posted:
    Aug 24, 2020
    Last Verified:
    Aug 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Asthma
    Emergencies

    Study Results

    No Results Posted as of Aug 24, 2020